60
Participants
Start Date
July 31, 2005
Primary Completion Date
September 30, 2007
Study Completion Date
March 31, 2008
nicardipine
"Intravenous (IV) nicardipine infusion. It is expected that the treatment duration will vary between 18 and 24 hours.~* Started at 5mg/h~* Titrated by 2.5mg/hour every 15 minutes to bring systolic blood pressure in target range for the applicable Tier. Max dose 15mg/hour \*Once target systolic blood pressure reached, dose decreased by 2.5mg/hour every 15 minutes until systolic blood pressure maintained in the target range or the medication is discontinued."
Columbia University Medical Center, New York
Statistical Coordinating Center: Medical University of South Carolina, Charleston
Ohio State University, Columbus
Case Western Reserve University, Cleveland
Clinical Coordinating Center: University of Minnesota, Fairview Hospital, Minneapolis
Saint Louis University, St Louis
Kansas University Medical Center, Kansas City
The University of Kansas School of Medicine, Wichita Via Christi Regional Medical Center, Kansas City
University of Southern California, Los Angeles
Massachusetts General/Brigham Women's Hospital, Boston
JFK Medical Center, Edison
University of Medicine and Dentistry of New Jersey, Newark
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Minnesota
OTHER